Peer-reviewedCC BYFrontiers in immunology
Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies
- 1The Second School of Medicine, Wenzhou Medical University , , ,
- 2Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University , , ,
- 3School of Laboratory Medicine and Life Sciences, Wenzhou Medical University , , ,
Related
- Antigen-Presentation Competence in Gynecologic Cancers: Mechanisms, Evidence and Translational Priorities.
- The hormone–microbiota–NET framework in gynecologic diseases: evidence, controversies, and translational opportunities
- Adaptive landscape of the metallo-β-lactamase NDM-1 to emerging β-lactam-based therapies
- Mechanoinflammation in osteoarthritis: knowledge evolution, cellular interactions, and translational research priorities
- Changes in the translational landscape during red clover necrotic mosaic virus infection
BibTeX
@article{chen2026clinical,
title = {{Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies}},
author = {Qingyu Chen and Yuxin Zhu and Shilin Ye and Yaoyi Wang and Huilong Lin},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655096},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies
AU - Qingyu Chen
AU - Yuxin Zhu
AU - Shilin Ye
AU - Yaoyi Wang
AU - Huilong Lin
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13655096
SN - 1664-3224
ER -